Unión Europea - español - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - cerdos - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

schering plough, s.a. - escherichia coli f4 ab (k88 ab), escherichia coli f4 ac (k88 ac), escherichia coli f5 (k99), escherichia coli f6 (987p), clostridium perfringens tipo b, toxoide beta (veterinaria), clostridium perfringens tipo e - suspensiÓn inyectable - excipientes: tiomersal, hidroxido de aluminio gel, formaldehido, cloruro de sodio, agua para preparaciones inyectables - escherichia + clostridium - porcino

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios hipra, s.a. - escherichia coli f4 ab (k88 ab), escherichia coli f4 ac (k88 ac), escherichia coli f5 (k99), escherichia coli f6 (987p), enterotoxoide lt de e. coli - emulsiÓn inyectable - excipientes: aceite mineral, montanide 888, simulsol 5100, timerosal, pbs - escherichia - cerdas